Publications

Patient-derived glioblastoma organoids reveal glioblastoma resistance to standard therapies

12.06.2023

A three-dimensional glioblastoma model for NK cell immunotherapy research

12.06.2023

Glioblastoma patient-derived organoids as a model for discovering novel markers of therapy resistance in the context of tumor microenvironment: potential role of melanoma antigens

16.04.2023

Combined Toxic Effects of BPA and Its Two Analogues BPAP and BPC in a 3D HepG2 Cell Model

30.03.2023

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo

17.01.2023

Adverse (geno)toxic effects of bisphenol A and its analogues in hepatic 3D cell model

24.12.2022

Discover More About the Project

The overarching aim of CutCancer is to improve the scientific excellence and innovation capacity in the field of 3D in vitro cancer research at the National Institute of Biology, Slovenia.